Annual Operating Expenses
$38.08 M
+$9.16 M+31.67%
December 31, 2023
Summary
- As of February 8, 2025, SABS annual total operating expenses is $38.08 million, with the most recent change of +$9.16 million (+31.67%) on December 31, 2023.
- During the last 3 years, SABS annual operating expenses has risen by +$58.63 million (+285.22%).
- SABS annual operating expenses is now at all-time high.
Performance
SABS Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$11.31 M
+$1.11 M+10.86%
September 30, 2024
Summary
- As of February 8, 2025, SABS quarterly total operating expenses is $11.31 million, with the most recent change of +$1.11 million (+10.86%) on September 30, 2024.
- Over the past year, SABS quarterly operating expenses has increased by +$5.99 million (+112.47%).
- SABS quarterly operating expenses is now -40.08% below its all-time high of $18.87 million, reached on December 31, 2023.
Performance
SABS Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
SABS Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +31.7% | +112.5% |
| 3 y3 years | +285.2% | +44.9% |
| 5 y5 years | +214.3% | +44.9% |
SABS Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +184.3% | -40.1% | +112.5% |
| 5 y | 5-year | at high | +285.2% | -40.1% | +1489.5% |
| alltime | all time | at high | +285.2% | -40.1% | +1489.5% |
SAB Biotherapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $11.31 M(+10.9%) |
| Jun 2024 | - | $10.20 M(-10.4%) |
| Mar 2024 | - | $11.39 M(-39.6%) |
| Dec 2023 | $38.08 M(+31.7%) | $18.87 M(+254.6%) |
| Sep 2023 | - | $5.32 M(-17.8%) |
| Jun 2023 | - | $6.48 M(-12.5%) |
| Mar 2023 | - | $7.40 M(-5.8%) |
| Dec 2022 | $28.92 M | $7.86 M(+0.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $7.81 M(+19.3%) |
| Jun 2022 | - | $6.54 M(-2.5%) |
| Mar 2022 | - | $6.71 M(-8.7%) |
| Dec 2021 | $13.39 M(-165.2%) | $7.34 M(+84.0%) |
| Sep 2021 | - | $3.99 M(+38.9%) |
| Jun 2021 | - | $2.87 M(-452.9%) |
| Mar 2021 | - | -$813.90 K |
| Dec 2020 | -$20.56 M(-269.7%) | - |
| Dec 2019 | $12.12 M | - |
FAQ
- What is SAB Biotherapeutics annual total operating expenses?
- What is the all time high annual operating expenses for SAB Biotherapeutics?
- What is SAB Biotherapeutics annual operating expenses year-on-year change?
- What is SAB Biotherapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for SAB Biotherapeutics?
- What is SAB Biotherapeutics quarterly operating expenses year-on-year change?
What is SAB Biotherapeutics annual total operating expenses?
The current annual operating expenses of SABS is $38.08 M
What is the all time high annual operating expenses for SAB Biotherapeutics?
SAB Biotherapeutics all-time high annual total operating expenses is $38.08 M
What is SAB Biotherapeutics annual operating expenses year-on-year change?
Over the past year, SABS annual total operating expenses has changed by +$9.16 M (+31.67%)
What is SAB Biotherapeutics quarterly total operating expenses?
The current quarterly operating expenses of SABS is $11.31 M
What is the all time high quarterly operating expenses for SAB Biotherapeutics?
SAB Biotherapeutics all-time high quarterly total operating expenses is $18.87 M
What is SAB Biotherapeutics quarterly operating expenses year-on-year change?
Over the past year, SABS quarterly total operating expenses has changed by +$5.99 M (+112.47%)